Announcement on Expected Loss in Performance and Risk Warning in 2025
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Expected Loss in Performance and Risk Warning in 2025
Filed with SSE · · 3 pages · Chinese
Release
Qinghai Spring Medicinal Resources Technology Co.,Ltd. on 6ix
Earlier from Qinghai Spring Medicinal Resources Technology Co.,Ltd
- Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business License
- Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
- Announcement on the Reply to the Regulatory Business Letter from SSE on Information Disclosure for Qinghai Spring’s Report for Q3 2025
- Announcement on Changing the Business Scope and Amending Some Clauses of the Articles of Association
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
Later from Qinghai Spring Medicinal Resources Technology Co.,Ltd
- Announcement on Risk Warning in Possible Termination of Stock Listing
- Announcement on Receiving Letter of Regulation Regarding Earnings Preannouncement for 2025 from the Shanghai Stock Exchange
- Indicative Announcement on the 2nd Risk Alert of Possible Termination of Listing of the Company's Stock
- Announcement on Extension of Time to Reply to the Shanghai Stock Exchange's "Letter of Regulation Regarding Matters Related to Qinghai Spring's Earnings Preannouncement for 2025"
- Indicative Announcement on the 3rd Risk Alert of Possible Termination of Listing of the Company's Stock
Follow Qinghai Spring Medicinal Resources Technology Co.,Ltd into a list and get an email when it puts out news.
Follow Qinghai Spring Medicinal Resources Technology Co.,Ltd